2018 American Transplant Congress

June 2-6, 2018 in Seattle, WA

View by Title View Sessions

View by Date

Saturday, June 2, 2018

5:30pm-7:30pm: The Impact of Childhood Solid Organ Transplantation on B-Cell Maturation

L. Ionescu,¹ T. Blydt-Hansen,² B. Foster,⁷ S. Mital,³ L. Hamiwka,⁵ U. Allan,³ V. Phan,⁴ P. Birk,⁶ C. Morgan,¹ S. Urschel.¹

Poster Session A: Biomarkers, Immune Monitoring and Outcomes • Hall 4EF

5:30pm-7:30pm: The Impact of Immunosuppression on Mineral Metabolism One Year after Kidney Transplantation: Differences between a Mycophenolate-Based Regimen versus an mTOR-Inhibitor-Based One

D. Cucchiari,¹ S. Karam,² P. Ventura-Aguiar,¹ F. Diekmann,¹ J. Torregrosa.¹

Poster Session A: Kidney: Cardiovascular and Metabolic • Hall 4EF

5:30pm-7:30pm: The Impact of Obesity on Incidence of Vascular Complications after Liver Transplantation: A Meta-Analysis

R. Deng, Y. Shi, B. Huang, Y. Ma.

Poster Session A: Liver Retransplantation and Other Complications • Hall 4EF

5:30pm-7:30pm: The Impact of Pre-Transplant Donor Specific Antibodies (DSA) on AMR Rates in HIV-Infected Kidney Transplant Recipients Inducted with IL-2 RA

S. Farouk, B. Rollins, V. Delaney, N. Singh, V. Sehgal, R. Kent, M. Menon, R. Shapiro, S. Florman, G. DeBoccardo.

Poster Session A: Kidney Acute Antibody Mediated Rejection • Hall 4EF

5:30pm-7:30pm: The Implications of Impaired Glucose Tolerance after Kidney Transplantation

F. Tinney, Jr.,¹ S. Norman,² A. Naik,² D. Cibrik,² R. Sung,² D. Frietze,³ M. Stegall,⁴ M. Samaniego,² C. Jay.³

Poster Session A: Kidney: Cardiovascular and Metabolic • Hall 4EF

5:30pm-7:30pm: The Incidence and Outcome of Isolated Distal Deep Vein Thrombosis in Kidney Transplant Recipient

M. Kim, J. Hwang, S. Kim, S. Park, I. Moon, J. Kim.

Poster Session A: Kidney: Cardiovascular and Metabolic • Hall 4EF

5:30pm-7:30pm: The Inhibitory Effect of Plasma on Activation of Lymphocytes from Kidney Transplants is Significantly More Severe in Tacrolimus Based Regimen: What Implications for Plasma Exchange Role in Anti-Rejection Therapy?

A. Assounga,^1,2 S. Omarjee.¹

Poster Session A: Biomarkers, Immune Monitoring and Outcomes • Hall 4EF

5:30pm-7:30pm: The Initial Hepatic Artery Reperfusion versus Initial Portal Reperfusion in Liver Transplantation: Where Do We Stand?

R. Shahbazov,¹ F. Azari,³ J. Alejo,² M. Talanian,² M. Fox,² K. Kennedy,² S. Kessel,² A. Nickkholgh,¹ D. Maluf,¹ S. Pelletier.¹

Poster Session A: Liver Retransplantation and Other Complications • Hall 4EF

5:30pm-7:30pm: The Likelihood of Re-Transplantation in Patients Undergoing Allograft Nephrectomy

G. Lucisano,¹ P. Brookes,² E. Santos-Nunez,² N. Firmin,² N. Gunby,² S. Hassan,¹ A. Gueret-Wardle,¹ M. Willicombe,¹ D. Taube.¹

Poster Session A: Biomarkers, Immune Monitoring and Outcomes • Hall 4EF

5:30pm-7:30pm: The LncRNA MALAT1 Induces Tolerogenic DCs and Antigen Specific Tregs Subsequently Mediating Cardiac Allograft Tolerance in Mice via MiR-155/DC-SIGN/IL10 Axis

M. Zhang,^1,2 J. Wu,^1,2 H. Zhang,^1,2 M. Liu,^1,2 Y. Zheng,^1,2 X. Jin,^1,2 S. Li,^1,2 Q. Zhao,^1,2 X. Liu,^1,2 Y. Sun,^1,2 B. Yu.^1,2

Poster Session A: Tolerance / Immune Deviation • Hall 4EF